Diskussionsleiter: M. Haude (Neuss), J. Schrader (Düsseldorf)
| (P1048) | Improvement of gene-therapy method by delivering positive charge surface nanoparticle coated recombinant adeno-associated-viurs into Cardiomyocyte of tomato mice. |
| S. Lee, T. Trenkwalder, C. Kieu, R. Hinkel, A. Schmidt, M. Ogris, C. Kupatt (München) | |
| (P1049) | Ansätze zur Steigerung der Effizienz und Spezifität des kardialen Gentransfers mittels AAV9-Vektoren |
| A. Jungmann, S. Schinkel, S. Werfel, J. Ksienzyk, M. Welzel, H. A. Katus, O. J. Müller (Heidelberg) | |
| (P1050) | Revacept (dimeres GPVI-Fc) verbessert die Infarktgröße, Prognose und neurologische Defizite bei ischämischem Schlaganfall |
| M. Ungerer, Z. Li, S. Wagner, J. Vogelmann, H.-P. Holthoff, A. Bültmann, M. Gawaz, G. Münch (Martinsried, Tübingen) | |
| (P1051) | Site directed vascular gene delivery by ultrasonic destruction of magnetic nanoparticle coated microbubbles |
| H. Mannell, J. Pircher, F. Fochler, B. Gleich, C. Plank, O. Mykhaylyk, C. Dahmani, U. Pohl, F. Krötz (München, Garching) | |
| (P1052) | Vitamin K (VK) supplementation rescues procalcifying aortic mRNA changes in a murine model of chronic kidney disease |
| V. Veulemans, D. Scheiber, P. Horn, D. Stern, M. M. Vorpahl, M. Chatrou, S. Potthoff, L. Schurgers, M. Kelm, R. Westenfeld (Düsseldorf; Maastricht, NL) | |
| (P1053) | Rotwein inhibiert substanziell die Atherogenese in LDL-Rezeptor-defizienten Mäusen |
| J. Sparwel, A. Borgard, M. Ndolumingo, J. Schnitker, M. Vantler, E. Caglayan, S. Rosenkranz (Köln) | |
| (P1054) | Bortezomib treatment of LDLR-KO mice with advanced atherosclerotic lesions influences plaque composition |
| N. Wilck, M. Fechner, K. Stangl, V. Stangl, A. Ludwig (Berlin) | |
| (P1055) | Nitrite is a regulator of hypoxic vasodilation |
| M. Totzeck, U. Hendgen-Cotta, P. Lüdike, M. Berenbrink, J. Klare, H.-J. Steinhoff, D. Semmler, S. Shiva, D. Williams, A. Kipar, M. Gladwin, J. Schrader, M. Kelm, A. Cossins, T. Rassaf (Düsseldorf, Osnabrück; Liverpool, UK; Pittsburgh, US) | |
| (P1056) | Induction of human vascular protease-activated receptor-2 by activated factor X and oxidative stress |
| K. Jobi, B. H. Rauch, A. Doller, W. Eberhardt, J. W. Fischer, K. Schrör, A. Fender (Düsseldorf, Greifswald, Frankfurt am Main) | |
| (P1057) | Targeted positioning of endothelial cells to the injured mouse carotid artery using magnetic nanoparticles |
| U. M. Becher, K. Zimmermann, D. Wenzel, B. Fleischmann, G. Nickenig, N. Werner, A. Pfeifer (Bonn) | |
| (P1058) | Negative Regulation of Hif-1α via the natural antisense transcript ahif - Consequences for the hypoxic gene regulation - |
| D. M. Poitz, A. Augstein, R. Braun-Dullaeus, A. Schmeißer, R. H. Strasser (Dresden, Magdeburg) |